Equities researchers at Evercore ISI assumed coverage on shares of Health Catalyst (NASDAQ:HCAT) in a report issued on Monday, MarketBeat.com reports. The firm set an “outperform” rating and a $50.00 price target on the stock. Evercore ISI’s price objective suggests a potential upside of 15.61% from the company’s previous close.
Shares of HCAT opened at $43.25 on Monday. Health Catalyst has a 52-week low of $36.29 and a 52-week high of $49.85.
About Health Catalyst
Read More: What is the operating income formula?
Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.